search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
TESTING


indicative and inhibitory properties. Also utilized in the test(s) are validated


chemical neutralizers at dilution ratios confirmed to inhibit antimicrobial activity present in the sample (e.g. the presence of chemical preservatives). The pathway through which these properties are validated is referred to as suitability testing or method validation. Alternative testing methods can include


DNA and RNA detection/identification, antibody-based detection, rapid biochemical/ metabolic detection/identification, and other quantitative detection methods that may require specialized equipment. Alternative methods of testing are in various stages of development and implementation, and are often specialized and associated with higher costs than traditional, culture-based testing methods.16 Procedures for microbiological limits


testing and applicable suitability controls are summarized herein from harmonized methods in the United States Pharmacopeia (USP) chapters <61> and <62>, European Pharmacopeia (EP) 2.6.12 and 2.6.13., and ISO 21149 and 18415.17-22


Quantitative test limits Quantitative limit tests are performed via sample enumeration; for this reason, they are often referred to as microbial count, total plate count, total viable count, or similar. In this design, a representative sample of product is plated to permissive solid media to recover


any bacteria, yeasts, or moulds present. Enumeration plates are incubated in


optimal growth conditions for a prescribed duration, then evaluated so that the total number of colony-forming units (CFU) per millilitre or gram of test material can be calculated.


Qualitative limit tests Qualitative limit tests are performed via sample enrichment and subculture. The first step, enrichment, mirrors the quantitative test in that a representative sample of product is transferred to permissive media; however, in this context it is liquid media that will support exponential reproduction of any microorganisms present. The enrichment step will allow for detection


of specified objectionable organisms, even if present at a low concentration – it should be noted that it is possible for a product to fail qualitative criteria for microbiological limits testing even if quantitative assessments demonstrate conformance. The enrichment step is followed by


a subculture step, in which media with selective and/or differential properties to screen for specific organisms of interest is implemented. Growth media containing a selective component will prevent growth of non-target organisms and/or cause indicative morphological reactions based on biochemical characteristics: for example, the high salt content of Mannitol salt agar will inhibit


29


growth of many organisms incidental to Staphylococci that cannot tolerate such stress conditions Further, fermentation of sugars in the


agar by different strains of Staphylococci will result in characteristic visual morphologies so that, for instance, Staphylococcus aureus can be distinguished from Staphylococcus epidermidis. Most qualitative screening tests use a similar combination of selective and differential factors to demonstrate whether recovered organisms represent those identified as objectionable. Organisms may be categorized as


objectionable where their presence in a formulation poses an increased risk to the consumer. While this may vary on a product- to-product basis, references such as the ISO 17516 propose that cosmetic products demonstrate absence of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Candida albicans. Complementary to microbiological limits


testing is the assessment of preservative efficacy, or preservative efficacy testing (PET). Preservative efficacy is assessed by challenging products via the introduction of microorganisms representative of contamination that products may be exposed to during manufacture, transport, and regular use.


Typically, Staphylococcus aureus,


Escherichia coli, Pseudomonas aeruginosa, Candida albicans, and Aspergillus brasiliensis


www.personalcaremagazine.com


May 2024 PERSONAL CARE


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92